摘要
With the widespread increase in energy intake and physical inactivity,the prevalence of metabolic health is declining.Consequently,metabolic associated fatty liver disease(MAFLD)[formerly known as non-alcoholic fatty liver disease(NAFLD)]has risen in prevalence and present a significant challenge to global health causing considerable morbidity and mortality,particularly when fibrosis is present(1).
基金
ME is supported by the Robert W.Storr Bequest to the Sydney Medical Foundation,University of Sydney
National Health and Medical Research Council of Australia(NHMRC)Program Grants(1053206 and 1149976)
Project grants(1107178 and 1108422,2001692).
